Advertisement
Screener

Infinity Pharmaceuticals, Inc. Proceeds from Stock Options Exercised

Infinity Pharmaceuticals, Inc. Proceeds from Stock Options Exercised

Infinity Pharmaceuticals, Inc. reported Proceeds from Stock Options Exercised of $200.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-14.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromStockOptionsExercised · last filed 2019-03-14

  • Infinity Pharmaceuticals, Inc. proceeds from stock options exercised for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
  • Infinity Pharmaceuticals, Inc. proceeds from stock options exercised for the quarter ending 2016-12-31 was -$130.00K, a 266.67% decline year-over-year.
  • Infinity Pharmaceuticals, Inc. proceeds from stock options exercised for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
  • Infinity Pharmaceuticals, Inc. proceeds from stock options exercised for the quarter ending 2016-06-30 was $401.00K, a 24.48% decline year-over-year.
  • Infinity Pharmaceuticals, Inc. proceeds from stock options exercised for fiscal 2018 was $200.00K.
  • Infinity Pharmaceuticals, Inc. proceeds from stock options exercised for fiscal 2016 was $314.00K, a 83.17% decline from fiscal 2015.
  • Infinity Pharmaceuticals, Inc. proceeds from stock options exercised for fiscal 2015 was $1.87M, a 51.92% decline from fiscal 2014.
  • Infinity Pharmaceuticals, Inc. proceeds from stock options exercised for fiscal 2014 was $3.88M, a 26.76% decline from fiscal 2013.
Period endProceeds from Stock Options Exercised 3 monthProceeds from Stock Options Exercised 6 monthProceeds from Stock Options Exercised 9 monthProceeds from Stock Options Exercised 12 monthProceeds from Stock Options Exercised 12 month as first filed
2018-12-31$200.00K
10-K · filed 2019-03-14
2017-03-31$0.00
10-Q · filed 2017-05-09
-$130.00K
derived: sum of 2 quarters · filed 2017-05-09
-$130.00K
derived: sum of 3 quarters · filed 2017-05-09
$271.00K
derived: sum of 4 quarters · filed 2017-05-09
2016-12-31-$130.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14
-$130.00K
derived: sum of 2 quarters · filed 2017-03-14
$271.00K
derived: sum of 3 quarters · filed 2017-03-14
$314.00K
10-K · filed 2017-03-14
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$401.00K
derived: sum of 2 quarters · filed 2016-11-09
$444.00K
10-Q · filed 2016-11-09
$522.00K
derived: sum of 4 quarters · filed 2017-05-09
2016-06-30$401.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$444.00K
10-Q · filed 2016-08-09
$522.00K
derived: sum of 3 quarters · filed 2017-05-09
$617.00K
derived: sum of 4 quarters · filed 2017-05-09
2016-03-31$43.00K
10-Q · filed 2017-05-09
$121.00K
derived: sum of 2 quarters · filed 2017-05-09
$216.00K
derived: sum of 3 quarters · filed 2017-05-09
$747.00K
derived: sum of 4 quarters · filed 2017-05-09
2015-12-31$78.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14
$173.00K
derived: sum of 2 quarters · filed 2017-03-14
$704.00K
derived: sum of 3 quarters · filed 2017-03-14
$1.87M
10-K · filed 2017-03-14
2015-09-30$95.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$626.00K
derived: sum of 2 quarters · filed 2016-11-09
$1.79M
10-Q · filed 2016-11-09
$2.70M
derived: sum of 4 quarters · filed 2017-03-14
2015-06-30$531.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$1.69M
10-Q · filed 2016-08-09
$2.60M
derived: sum of 3 quarters · filed 2017-03-14
$3.51M
derived: sum of 4 quarters · filed 2017-03-14
2015-03-31$1.16M
10-Q · filed 2016-05-04
$2.07M
derived: sum of 2 quarters · filed 2017-03-14
$2.98M
derived: sum of 3 quarters · filed 2017-03-14
$3.09M
derived: sum of 4 quarters · filed 2017-03-14
2014-12-31$908.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14
$1.82M
derived: sum of 2 quarters · filed 2017-03-14
$1.93M
derived: sum of 3 quarters · filed 2017-03-14
$3.88M
10-K · filed 2017-03-14
2014-09-30$913.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$1.02M
derived: sum of 2 quarters · filed 2015-11-05
$2.97M
10-Q · filed 2015-11-05
$3.73M
derived: sum of 4 quarters · filed 2016-02-23
2014-06-30$108.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$2.06M
10-Q · filed 2015-08-06
$2.81M
derived: sum of 3 quarters · filed 2016-02-23
$3.73M
derived: sum of 4 quarters · filed 2016-02-23
2014-03-31$1.95M
10-Q · filed 2015-05-06
$2.71M
derived: sum of 2 quarters · filed 2016-02-23
$3.62M
derived: sum of 3 quarters · filed 2016-02-23
$4.78M
derived: sum of 4 quarters · filed 2016-02-23
2013-12-31$754.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23
$1.67M
derived: sum of 2 quarters · filed 2016-02-23
$2.82M
derived: sum of 3 quarters · filed 2016-02-23
$5.30M
10-K · filed 2016-02-23
2013-09-30$917.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$2.07M
derived: sum of 2 quarters · filed 2014-11-10
$4.54M
10-Q · filed 2014-11-10
$17.06M
derived: sum of 4 quarters · filed 2015-02-24
2013-06-30$1.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$3.63M
10-Q · filed 2014-08-11
$16.14M
derived: sum of 3 quarters · filed 2015-02-24
$21.82M
derived: sum of 4 quarters · filed 2015-02-24
2013-03-31$2.48M
10-Q · filed 2014-05-06
$14.99M
derived: sum of 2 quarters · filed 2015-02-24
$20.66M
derived: sum of 3 quarters · filed 2015-02-24
2012-12-31$12.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24
$18.19M
derived: sum of 2 quarters · filed 2015-02-24
$21.39M
10-K · filed 2015-02-24
$21.40M
10-K · filed 2013-03-05
2012-09-30$5.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
$8.87M
10-Q · filed 2013-11-07
2012-06-30$3.20M
10-Q · filed 2013-08-08
2011-12-31$582.00K
10-K · filed 2014-02-25